SCHEMBL24919780

SCHEMBL24919780

c1ccc(-c2ccccc2N(c2cccc(-c3ccc4ccccc4c3)c2)c2cccc3sc4ccccc4c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.37
S1PR4 O95977 6/20 0.37
HSD17B1 P14061 2/20 0.33
HSD17B2 P37059 2/20 0.33
F9 P00740 1/20 0.33
CDK4 P11802 3/20 0.31
CCND1 P24385 3/20 0.31
ALOX5 P09917 1/20 0.30
ACMSD Q8TDX5 1/20 0.30
CCNB2 O95067 1/20 0.30
CCNE2 O96020 1/20 0.30
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
CCNB3 Q8WWL7 1/20 0.30
SLC9A1 P19634 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27273775 1.00 S1PR5 (0.37) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL23225297 0.99 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL27273776 0.99 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL24471803 0.96 S1PR5 (0.35) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL24472157 0.95 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL27273079 0.94 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL27273085 0.94 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL24964686 0.94 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL27273083 0.94 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9
SCHEMBL27273081 0.94 S1PR5 (0.36) S1PR5S1PR4HSD17B1HSD17B2F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 S1PR5 4793/4885S1PR4 4518/4885HSD17B1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.